Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility
Pavel Uhrin, … , Bernd R. Binder, Margarethe Geiger
Pavel Uhrin, … , Bernd R. Binder, Margarethe Geiger
Published December 15, 2000
Citation Information: J Clin Invest. 2000;106(12):1531-1539. https://doi.org/10.1172/JCI10768.
View: Text | PDF
Article

Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility

  • Text
  • PDF
Abstract

Protein C inhibitor (PCI) is a nonspecific, heparin-binding serpin (serine protease inhibitor) that inactivates many plasmatic and extravascular serine proteases by forming stable 1:1 complexes. Proteases inhibited by PCI include the anticoagulant activated protein C, the plasminogen activator urokinase, and the sperm protease acrosin. In humans PCI circulates as a plasma protein but is also present at high concentrations in organs of the male reproductive tract. The biological role of PCI has not been defined so far. However, the colocalization of high concentrations of PCI together with several of its target proteases in the male reproductive tract suggests a role of PCI in reproduction. We generated mice lacking PCI by homologous recombination. Here we show that PCI–/– mice are apparently healthy but that males of this genotype are infertile. Infertility was apparently caused by abnormal spermatogenesis due to destruction of the Sertoli cell barrier, perhaps due to unopposed proteolytic activity. The resulting sperm are malformed and are morphologically similar to abnormal sperm seen in some cases of human male infertility. This animal model might therefore be useful for analyzing the molecular bases of these human conditions.

Authors

Pavel Uhrin, Mieke Dewerchin, Mario Hilpert, Peter Chrenek, Christian Schöfer, Margareta Zechmeister-Machhart, Gerhard Krönke, Anja Vales, Peter Carmeliet, Bernd R. Binder, Margarethe Geiger

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
(a) Tissue distribution of PCI mRNA determined by RT-PCR using 1 μg of R...
(a) Tissue distribution of PCI mRNA determined by RT-PCR using 1 μg of RNA as template. Lane 1, PhiX 174/HaeIII marker; lane 2, testes of PCI–/– males; lane 3, ovaries of PCI–/– females; lane 4, seminal vesicles of PCI+/+ males; lane 5, testes of PCI+/+ males; lane 6, epididymides of PCI+/+ males; lane 7, prostates of PCI+/+ males; lane 8, ovaries of PCI+/+ females; lane 9, uteri of PCI+/+ females; lane 10, negative control. (b) Western blots. Crude Triton X-100 testis extracts (100 μg protein/lane) of PCI+/+ (lane 1) and PCI–/– (lane 2) mice are shown. Lane 3, recombinant mPCI (50 ng/lane). The samples in lanes 4–6 correspond to the samples in lanes 1–3, but they were incubated with preimmune serum only. (c) ELISA. PCI antigen concentration in crude Triton X-100 testis extracts (10 mg of total protein/ml) of PCI+/+ (lane 1) and of PCI–/– (lane 2) mice. ANo measurable antigen. Lane 3, A405 nm of 50% serum from PCI+/+ mice; lane 4, A405 nm of 50% serum from PCI–/– mice; lane 5, A405 nm of 50% serum from PCI+/+ mice with addition of 200 ng/ml recombinant mPCI (obtained value correlated with standard curve of the assay; not shown).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts